معرفی
Katja Csarmann (BSc, MSc) is a researcher at the Department of Nutritional Sciences within the Faculty of Life Sciences, specializing in metabolic and liver disease pathophysiology. Her current work focuses on diet-induced nonalcoholic fatty liver disease mechanisms and therapeutic interventions.
Her research interests center on gut-liver axis interactions, particularly how intestinal flora influences metabolic dysfunction-associated steatotic liver disease (MASLD). Key areas include:
- Antibiotic modulation of gut microbiota in liver disease
- Tight junction integrity and intestinal barrier function
- TLR4 signaling in immunometabolism
- 4-methylpyrazole as a therapeutic agent for MASLD
- Dietary interventions (vegan vs. omnivorous) on metabolic health
Her publication trends reveal a strong emphasis on translational models of liver disease, with recent work analyzing blood plasma biomarkers, fecal microbiota composition, and JNK pathway involvement in non-obese MASLD. Collaborative projects frequently investigate LPS-induced immune activation and amino acid supplementation effects.
Current research activities include:
- Presenting on vegan diet effects on general health parameters (October 2024)
- Studying iso-alpha acid hop extracts on immune cell activation (October 2024)
- Investigating L-arginine supplementation in alcohol-related liver disease (June 2024)
